David Westover
Impact in
- Oncology top 5%
- Lung Cancer Research Studies
- HER2/EGFR in Cancer Research
- Colorectal Cancer Treatments and Studies
-
- Lung Cancer Treatments and Mutations
Papers in
- Oncology 7
- Drug Transport and Resistance Mechanisms 2
- Cancer-related Molecular Pathways 2
- Lung Cancer Research Studies 1
-
- Cancer therapeutics and mechanisms 3
- Co-authors
- Christine M. Lovly (5 shared papers)Byoung Chul Cho (1 shared paper)J. Zugazagoitia (1 shared paper)Luis Paz‐Ares (1 shared paper)Fengzhi Li (4 shared papers)Joshua A. Bauer (4 shared papers)Yingjun Yan (2 shared papers)David J. Wooten (1 shared paper)
- Journals
- Cancer Research (2 papers)Molecular Cancer (1 paper)Annals of Oncology (1 paper)Clinical Cancer Research (1 paper)Journal of Experimental & Clinical Cancer Research (1 paper)
- Partner nations
- United StatesFranceSpain
In The Last Decade
David Westover
15 papers receiving 1.0k citations
David Westover's Hit Papers
Peers
Comparison fields: 5 of 78
- Oncology 410
- Pulmonary and Respiratory Medicine 472
- Cancer Research 148
- Molecular Biology 455
- Pathology and Forensic Medicine 60
Countries citing papers authored by David Westover
This map shows the geographic impact of David Westover's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Westover with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Westover more than expected).
Fields of papers citing papers by David Westover
This network shows the impact of papers produced by David Westover. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Westover. The network helps show where David Westover may publish in the future.
Co-authors
The 25 scholars most cited alongside David Westover, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Mechanisms of acquired resistance to first- and second-generation EGFR tyrosine kinase inhibitors Hit paper breakdown → | 2018 | 539 |
| 2 | 2019 | 122 | |
| 3 | 2017 | 106 | |
| 4 | 2019 | 80 | |
| 5 | 2015 | 79 | |
| 6 | 2015 | 57 | |
| 7 | 2024 | 26 | |
| 8 | 2020 | 13 | |
| 9 | Synergistic effect of allyl isothiocyanate (AITC) on cisplatin efficacy in vitro and in vivo. | 2015 | 12 |
| 10 | Safety and Feasibility of Rotational Atherectomy in Elderly Patients With Severe Aortic Stenosis. | 2017 | 8 |
| 11 | 2022 | 2 | |
| 12 | 2020 | 2 | |
| 13 | 2023 | 1 | |
| 14 | 2014 | 1 | |
| 15 | 2017 | 1 |
About David Westover
David Westover is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Organic Chemistry and Biomedical Engineering, having authored 15 papers that have together received 1.0k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (4 papers), Cancer therapeutics and mechanisms (3 papers), Drug Transport and Resistance Mechanisms (2 papers), Cancer-related Molecular Pathways (2 papers), Recycling and Waste Management Techniques (1 paper), Cancer Mechanisms and Therapy (1 paper), Lung Cancer Research Studies (1 paper) and Microplastics and Plastic Pollution (1 paper). The work is most often cited by research in Oncology (410 citations), Pulmonary and Respiratory Medicine (472 citations), Cancer Research (148 citations), Molecular Biology (455 citations) and Pathology and Forensic Medicine (60 citations). David Westover has collaborated with scholars based in United States, France and Spain. Frequent co-authors include Christine M. Lovly, Byoung Chul Cho, J. Zugazagoitia, Luis Paz‐Ares, Fengzhi Li, Joshua A. Bauer, Yingjun Yan, David J. Wooten, Leonard A. Harris and Keisha N. Hardeman. Their work appears in journals such as Cancer Research, Molecular Cancer, Annals of Oncology, Clinical Cancer Research and Journal of Experimental & Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.